Michael W. Handlogten

740 total citations
25 papers, 604 citations indexed

About

Michael W. Handlogten is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Michael W. Handlogten has authored 25 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Michael W. Handlogten's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Protein purification and stability (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Michael W. Handlogten is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Protein purification and stability (15 papers) and Viral Infectious Diseases and Gene Expression in Insects (13 papers). Michael W. Handlogten collaborates with scholars based in United States, Poland and Japan. Michael W. Handlogten's co-authors include Başar Bilgiçer, Sanjeev Ahuja, Tanyel Kiziltepe, Nathan J. Alves, Jared F. Stefanick, Min Zhu, Shailendra Singh, Gargi Roy, Jihong Wang and Demetri T. Moustakas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Biomaterials.

In The Last Decade

Michael W. Handlogten

25 papers receiving 595 citations

Peers

Michael W. Handlogten
Zhaozhong Han United States
Nico Mertens Belgium
Esteban Cruz Australia
Shunzi Li United States
James R. Kintzing United States
Zhaozhong Han United States
Michael W. Handlogten
Citations per year, relative to Michael W. Handlogten Michael W. Handlogten (= 1×) peers Zhaozhong Han

Countries citing papers authored by Michael W. Handlogten

Since Specialization
Citations

This map shows the geographic impact of Michael W. Handlogten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Handlogten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Handlogten more than expected).

Fields of papers citing papers by Michael W. Handlogten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Handlogten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Handlogten. The network helps show where Michael W. Handlogten may publish in the future.

Co-authorship network of co-authors of Michael W. Handlogten

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Handlogten. A scholar is included among the top collaborators of Michael W. Handlogten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Handlogten. Michael W. Handlogten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Betenbaugh, Michael J., et al.. (2024). Elevated endoplasmic reticulum pH is associated with high growth and bisAb aggregation in CHO cells. Biotechnology and Bioengineering. 122(1). 137–148. 2 indexed citations
2.
Handlogten, Michael W., Jie Zhu, Lina Li, et al.. (2023). Accelerated cell culture process development and characterization for cilgavimab/tixagevimab (AZD7442) for the prevention and treatment of COVID‐19. Biotechnology and Bioengineering. 122(9). 2308–2318. 3 indexed citations
3.
Zhu, Jie, et al.. (2022). Engineering redox sensors into CHO cells enables near‐real‐time quantification of intracellular redox in bioprocesses. Biotechnology and Bioengineering. 119(6). 1439–1449. 4 indexed citations
4.
Sinharoy, Pritam, et al.. (2021). Redox as a bioprocess parameter: analytical redox quantification in biological therapeutic production. Current Opinion in Biotechnology. 71. 49–54. 4 indexed citations
5.
Sinharoy, Pritam, et al.. (2020). Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells. Scientific Reports. 10(1). 16620–16620. 28 indexed citations
6.
Handlogten, Michael W., et al.. (2020). Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region. mAbs. 12(1). 1779974–1779974. 19 indexed citations
7.
Chung, Wai Keen, et al.. (2020). Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation. Biotechnology and Bioengineering. 117(4). 1063–1071. 15 indexed citations
8.
Handlogten, Michael W., et al.. (2017). Intracellular response to process optimization and impact on productivity and product aggregates for a high‐titer CHO cell process. Biotechnology and Bioengineering. 115(1). 126–138. 74 indexed citations
9.
Handlogten, Michael W., et al.. (2014). Two-Allergen Model Reveals Complex Relationship between IgE Crosslinking and Degranulation. Chemistry & Biology. 21(11). 1445–1451. 7 indexed citations
10.
Handlogten, Michael W., Ana Serezani, Anthony L. Sinn, et al.. (2014). A Heterobivalent Ligand Inhibits Mast Cell Degranulation via Selective Inhibition of Allergen–IgE Interactions In Vivo. The Journal of Immunology. 192(5). 2035–2041. 7 indexed citations
11.
Handlogten, Michael W., Tanyel Kiziltepe, Ana Serezani, Mark H. Kaplan, & Başar Bilgiçer. (2013). Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation. Nature Chemical Biology. 9(12). 789–795. 31 indexed citations
12.
Alves, Nathan J., Matthew M. Champion, Jared F. Stefanick, et al.. (2013). Selective photocrosslinking of functional ligands to antibodies via the conserved nucleotide binding site. Biomaterials. 34(22). 5700–5710. 29 indexed citations
13.
Alves, Nathan J., et al.. (2013). Functionalized liposome purification via Liposome Extruder Purification (LEP). The Analyst. 138(17). 4746–4746. 24 indexed citations
14.
Handlogten, Michael W., Jared F. Stefanick, Nathan J. Alves, & Başar Bilgiçer. (2013). Nonchromatographic Affinity Precipitation Method for the Purification of Bivalently Active Pharmaceutical Antibodies from Biological Fluids. Analytical Chemistry. 85(10). 5271–5278. 12 indexed citations
15.
Handlogten, Michael W., Tanyel Kiziltepe, & Başar Bilgiçer. (2012). Design of a heterotetravalent synthetic allergen that reflects epitope heterogeneity and IgE antibody variability to study mast cell degranulation. Biochemical Journal. 449(1). 91–99. 16 indexed citations
16.
Handlogten, Michael W., Tanyel Kiziltepe, Nathan J. Alves, & Başar Bilgiçer. (2012). Synthetic Allergen Design Reveals the Significance of Moderate Affinity Epitopes in Mast Cell Degranulation. ACS Chemical Biology. 7(11). 1796–1801. 16 indexed citations
17.
Stefanick, Jared F., Tanyel Kiziltepe, Michael W. Handlogten, Nathan J. Alves, & Başar Bilgiçer. (2012). Enhancement of Antibody Selectivity via Bicyclic Complex Formation. The Journal of Physical Chemistry Letters. 3(5). 598–602. 12 indexed citations
18.
Alves, Nathan J., et al.. (2012). Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting. Analytical Chemistry. 84(18). 7721–7728. 38 indexed citations
19.
Handlogten, Michael W., Tanyel Kiziltepe, Demetri T. Moustakas, & Başar Bilgiçer. (2011). Design of a Heterobivalent Ligand to Inhibit IgE Clustering on Mast Cells. Chemistry & Biology. 18(9). 1179–1188. 30 indexed citations
20.
Paraskar, Abhimanyu S., Shivani Soni, Padmaparna Chaudhuri, et al.. (2010). Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy. Proceedings of the National Academy of Sciences. 107(28). 12435–12440. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026